Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Malar J ; 13: 265, 2014 Jul 09.
Article in English | MEDLINE | ID: mdl-25007860

ABSTRACT

BACKGROUND: The effects that artemether-lumefantrine (AL) has on gametocyte dynamics in the short-term have recently been described. However there is limited long-term longitudinal data on the effect of AL on gametocyte dynamics in asymptomatic children. METHODS: An epidemiological study was conducted in Kombewa, Western Kenya, in which 270 asymptomatic children aged between 12 and 47 months were enrolled. The subjects were randomized to receive either a course of AL or placebo at enrolment. Active follow-up was conducted for one year. RESULTS: The gametocyte prevalence and density dynamics throughout the study period mirrored that of the asexual forms. The proportion of initially parasitaemic subjects becoming gametocytaemic was significantly lower in the AL arm for the first 12 weeks following randomization. The geometric mean gametocyte density was lower in the AL arm for 2 weeks following randomization. None of the variables of interest had a statistically significant effect on the duration of gametocytaemia. There is no effect seen in subjects who are not parasitaemic at the time of drug administration. CONCLUSIONS: The treatment of asymptomatic parasitaemic subjects with AL results in a significant reduction in the proportion of subjects who become gametocytaemic for at least 12 weeks.


Subject(s)
Antimalarials/therapeutic use , Artemisinins/therapeutic use , Carrier State/drug therapy , Carrier State/epidemiology , Ethanolamines/therapeutic use , Fluorenes/therapeutic use , Malaria, Falciparum/drug therapy , Malaria, Falciparum/epidemiology , Plasmodium falciparum/isolation & purification , Artemether, Lumefantrine Drug Combination , Carrier State/parasitology , Child, Preschool , Cohort Studies , Drug Combinations , Epidemiologic Studies , Female , Humans , Infant , Kenya/epidemiology , Longitudinal Studies , Malaria, Falciparum/parasitology , Male , Parasitemia/diagnosis , Placebos/therapeutic use
2.
Antimicrob Agents Chemother ; 58(7): 3737-43, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24752268

ABSTRACT

In combination with antibiotics, quinine is recommended as the second-line treatment for uncomplicated malaria, an alternative first-line treatment for severe malaria, and for treatment of malaria in the first trimester of pregnancy. Quinine has been shown to have frequent clinical failures, and yet the mechanisms of action and resistance have not been fully elucidated. However, resistance is linked to polymorphisms in multiple genes, including multidrug resistance 1 (Pfmdr1), the chloroquine resistance transporter (Pfcrt), and the sodium/hydrogen exchanger gene (Pfnhe1). Here, we investigated the association between in vitro quinine susceptibility and genetic polymorphisms in Pfmdr1codons 86 and 184, Pfcrt codon 76, and Pfnhe1 ms4760 in 88 field isolates from western Kenya. In vitro activity was assessed based on the drug concentration that inhibited 50% of parasite growth (the IC50), and parasite genetic polymorphisms were determined from DNA sequencing. Data revealed there were significant associations between polymorphism in Pfmdr1-86Y, Pfmdr1-184F, or Pfcrt-76T and quinine susceptibility (P < 0.0001 for all three associations). Eighty-two percent of parasites resistant to quinine carried mutant alleles at these codons (Pfmdr1-86Y, Pfmdr1-184F, and Pfcrt-76T), whereas 74% of parasites susceptible to quinine carried the wild-type allele (Pfmdr1-N86, Pfmdr1-Y184, and Pfcrt-K76, respectively). In addition, quinine IC50 values for parasites with Pfnhe1 ms4760 3 DNNND repeats were significantly higher than for those with 1 or 2 repeats (P = 0.033 and P = 0.0043, respectively). Clinical efficacy studies are now required to confirm the validity of these markers and the importance of parasite genetic background.


Subject(s)
Antimalarials/pharmacology , Drug Resistance/genetics , Genes, Protozoan/genetics , Membrane Transport Proteins/genetics , Multidrug Resistance-Associated Proteins/genetics , Plasmodium falciparum/drug effects , Protozoan Proteins/genetics , Quinine/pharmacology , Sodium-Hydrogen Exchangers/genetics , Alleles , Animals , DNA, Protozoan/genetics , Genes, Protozoan/physiology , Genotype , Humans , Kenya , Malaria, Falciparum/parasitology , Membrane Transport Proteins/physiology , Microsatellite Repeats , Molecular Sequence Data , Multidrug Resistance-Associated Proteins/physiology , Parasitic Sensitivity Tests , Polymorphism, Genetic/genetics , Protozoan Proteins/physiology , Sodium-Hydrogen Exchangers/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...